Results 31 to 40 of about 148,019 (190)

Aspergillus felis in Patient with Chronic Granulomatous Disease

open access: yesEmerging Infectious Diseases, 2019
We report a case of Aspergillus felis infection in a patient with chronic granulomatous disease who had overlapping features of invasive pulmonary aspergillosis and allergic bronchopulmonary aspergillosis.
Olivier Paccoud   +8 more
doaj   +1 more source

Allergic bronchopulmonary aspergillosis

open access: yesIndian Journal of Medical Research, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is an inflammatory disease caused by immunologic reactions initiated against Aspergillus fumigatus colonizing the airways of patients with asthma and cystic fibrosis. The common manifestations include treatment-resistant asthma, transient and fleeting pulmonary opacities and ...
Agarwal, Ritesh   +7 more
openaire   +2 more sources

Recurrent hemoptysis in a patient with bronchial asthma

open access: yesJournal of Advanced Lung Health, 2021
Hemoptysis is not a common symptom in bronchial asthma. We aim to discuss the approach to a patient with uncontrolled asthma with recurrent hemoptysis in this case-based discussion.
Vishnu M Sharma, Baseer Ahmmad Walikar
doaj   +1 more source

Pictorial essay: Allergic bronchopulmonary aspergillosis

open access: yesIndian Journal of Radiology and Imaging, 2011
Allergic bronchopulmonary aspergillosis (ABPA) is the best-known allergic manifestation of Aspergillus-related hypersensitivity pulmonary disorders. Most patients present with poorly controlled asthma, and the diagnosis can be made on the basis of a ...
Ritesh Agarwal   +4 more
doaj   +1 more source

Allergic bronchopulmonary Aspergillosis in children

open access: yesTURKISH JOURNAL OF MEDICAL SCIENCES, 2021
Allergic bronchopulmonary aspergillus (ABPA) is a lung disease caused by hypersensitivity from Aspergillus fumigatus. Diagnostic criteria, staging systems and treatment methods for ABPA disease have been reported in studies evaluating populations, the majority of which are adult patients.
Özge ATAY   +6 more
openaire   +3 more sources

Allergic bronchopulmonary aspergillosis: Indian scenario

open access: yesIndian Journal of Allergy Asthma and Immunology, 2019
Aspergillus is ubiquitous, occurring in mycelial form and grows at 15-530C and humid conditions. Pulmonary aspergillosis is a clinical spectrum of lung disease caused by the fungus Aspergillus.
Rajendra Prasad   +2 more
doaj   +1 more source

Criteria for the diagnosis of allergic bronchopulmonary aspergillosis.

open access: yes, 2013
Criteria for the diagnosis of allergic bronchopulmonary aspergillosis.
Dheeraj Gupta (56317)   +6 more
core   +1 more source

Tezepelumab treatment for allergic bronchopulmonary aspergillosis

open access: yesRespirology Case Reports, 2023
An 82‐year‐old man had been diagnosed with asthma. He experienced repeated exacerbations requiring treatment with a systemic corticosteroid despite being treated with medications including high‐dose fluticasone furoate/umeclidinium/vilanterol ...
Hiroaki Ogata   +8 more
doaj   +1 more source

Therapeutic potential of a Bax inhibitor‐1/TMBIM6 antagonist (BIA) and its analogues in Aspergillus fumigatus‐induced asthma via dual targeting of AKT and epithelial‐derived inflammatory cytokines

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 19, Page 5975-5991, October 2026.
Background and Purpose Aspergillus fumigatus (A. fumigatus) exposure causes of severe allergic asthma, characterized by airway inflammation and epithelial dysfunction. TMBIM6 (Bax inhibitor‐1) has been implicated in airway epithelial stress responses and AKT signalling.
Young‐Jin Yu   +7 more
wiley   +1 more source

Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis

open access: yes, 2008
The diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) is a challenge. Thymus- and activation-regulated chemokine (TARC) has recently been reported to play a role in ABPA.
Schoeni, M H   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy